Chemoinformaics analysis of 1,2,4-Butanetriol
| Molecular Weight | 106.121 | nRot | 3 |
| Heavy Atom Molecular Weight | 96.041 | nRig | 0 |
| Exact Molecular Weight | 106.063 | nRing | 0 |
| Solubility: LogS | 0.602 | nHRing | 0 |
| Solubility: LogP | -1.509 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 15.7539 |
| nHD | 3 | BPOL | 10.0321 |
| QED | 0.42 |
| Synth | 2.892 |
| Natural Product Likeliness | 2.068 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.011 |
| HIA | 0.721 |
| CACO-2 | -5.044 |
| MDCK | 0.00824637 |
| BBB | 0.239 |
| PPB | 0.090143 |
| VDSS | 0.821 |
| FU | 0.896129 |
| CYP1A2-inh | 0.015 |
| CYP1A2-sub | 0.092 |
| CYP2c19-inh | 0.014 |
| CYP2c19-sub | 0.218 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.154 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.116 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.065 |
| CL | 4.004 |
| T12 | 0.819 |
| hERG | 0.04 |
| Ames | 0.032 |
| ROA | 0.01 |
| SkinSen | 0.282 |
| Carcinogencity | 0.032 |
| EI | 0.987 |
| Respiratory | 0.025 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.960251 |